The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?

Volume: 19, Issue: 3, Pages: 747 - 747
Published: Mar 6, 2018
Abstract
The mechanistic target of rapamycin (mTOR) is part of the phosphoinositide-3-kinase (PI3K)/protein kinase B (AkT)/mTOR pathway and owes its name to the inhibitory effect of rapamycin. The mTOR has a central converging role for many cell functions, serving as a sensor for extracellular signals from energy status and nutrients availability, growth factors, oxygen and stress. Thus, it also modulates switch to anabolic processes (protein and lipid...
Paper Details
Title
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
Published Date
Mar 6, 2018
Volume
19
Issue
3
Pages
747 - 747
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.